Ajanta Pharma Ltd 2023 SR
The report highlights Ajanta Pharma's commitment to ESG integration, targeting 50% renewable energy by 2026 and 100% by 2032. It details significant progress in water conservation, aiming for a 30% reduction by 2026 and water positivity by 2030. The company reported Scope 1 emissions of 4,368.55 t CO2e and Scope 2 emissions of 51,813.33 t CO2e for FY 2023. Social initiatives include extensive CSR programs benefiting over 274,100 individuals in healthcare and education. Governance is bolstered by a dedicated ESG Committee and robust risk management frameworks.
Company: Ajanta Pharma Ltd
Sector: Health Care
Country: India
Year: 2023
Type: SR
Pages: 33
Ajanta Pharma Ltd
Business Responsibility And Sustainability Report
The report highlights Ajanta Pharma's commitment to ESG integration, targeting 50% renewable energy by 2026 and 100% by 2032. It details significant progress in water conservation, aiming for a 30% reduction by 2026 and water positivity by 2030. The company reported Scope 1 emissions of 4,368.55 t CO2e and Scope 2 emissions of 51,813.33 t CO2e for FY 2023. Social initiatives include extensive CSR programs benefiting over 274,100 individuals in healthcare and education. Governance is bolstered by a dedicated ESG Committee and robust risk management frameworks.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees